Crop Life Science logo

Crop Life Science financials and balance sheet

NSE: CLSLFertilizers & Agrochemicals

Last close ₹74.45up ₹3.50 (4.93%)

Share price at the NSE close on 22 Oct 2026. Previous close ₹70.95.

52-week range of traded prices to 22 Oct 2026
₹39.05Low, 1 Jun 2026₹92.25High, 26 Aug 2026
Market cap
₹128 Cr
P/E
19.6
P/B
1.5
Dividend yield
Nonein the last 12 months
ROE
8.0%
ROCE
9.1%
Debt to equity
0.61
Volume, NSE
14,000100.0% delivered

3 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Crop Life Science annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹207 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue207
  2. Materials and goods−151
  3. Employee costs−14
  4. Other expenses−24
  5. Operating profit18
  6. Depreciation−4.9
  7. Other income+1.8
  8. One-off items+0.1
  9. Finance costs−5.4
  10. Profit before tax9.2
  11. Tax−2.7
  12. Net profit6.5

What the company owns

  • Receivables₹74 Cr
  • Inventory₹71 Cr
  • Plant, investments and other assets₹60 Cr
  • Cash and bank₹3 Cr

What pays for it: net worth and liabilities

  • Net worth₹88 Cr
  • Borrowings₹54 Cr
  • Owed to suppliers₹52 Cr
  • Other liabilities₹14 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Crop Life Science half-yearly results

₹ croreMar 2024Mar 2025Filed 30 MayMar 2026Filed 26 May
Revenue from operations199201207
186184189
Materials and goods bought146142151
Employee costs111314
Other expenses283024
Operating profit before depreciation131618
Operating margin6.4%8.2%8.6%
Materials, % of revenue73.6%70.7%73.1%
Employee costs, % of revenue5.7%6.4%6.7%
Other expenses, % of revenue14.3%14.8%11.7%
Depreciation and amortisation355
Operating profit after depreciation91213
Other income212
Finance costs355
Profit before one-off items and tax–89
One-off items000
Profit before tax889
223
Net profit666
Other comprehensive income000
Total comprehensive income657
Net margin3.0%2.8%3.1%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2025Filed 30 MayMar 2026Filed 26 May
8188
7784
Share capital1717
Reserves6067
Belonging to outside owners of subsidiaries44
4154
93114
86
Total assets182208
4031
142177
Net debt4050
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the year to Mar 2024, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2025Filed 30 MayMar 2026Filed 26 May
−2.1−7.6
0.4−4.9
−16.8−24.4
Receivables8.2−5.5
Inventories−9.1−21.7
Payables−11.38.5
Other working capital−4.7−5.8
Tax paid−2.2−2.7
Capital spending3.91.9
Free cash flow−6.0−9.6
−3.51.6
4.221.9
Dividends paid0.00.0
Shares bought back0.00.0
Shares issued0.00.0
Net change in cash−1.415.9
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the year to Mar 2024.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2024Mar 2025Filed 30 MayMar 2026Filed 26 May
Earnings per share₹3.54₹3.15₹3.79
Diluted earnings per share₹3.54₹3.15₹3.79
Book value per share–₹45.19₹49.15
Shareholder yield–0.0%0.0%
Market cap at the year end (₹ crore)63.187.470.3

Ratios

Consolidated, years to March.Crop Life Science PE ratio and valuation

RatioMar 2024Mar 2025Filed 30 MayMar 2026Filed 26 May
Revenue growth–1.0%3.3%
Operating profit growth–30.1%8.2%
Net profit growth–−6.9%16.0%
Earnings per share growth–−11.0%20.3%
–7.2%8.0%
––0.8 pts
From the net margin––0.9 pts
From asset turnover––−0.3 pts
From borrowing––0.2 pts
Return on capital employed–9.5%9.1%
Cash conversion–−37.5%−117.5%
Interest cover2.82.42.4
Debt to equity–0.500.61
Receivable days–126131
Inventory days–126170
Payable days–107126
Cash conversion cycle, days–145175
Working capital days–157195
Asset turnover–1.101.06
Assets per rupee of net worth–2.352.41
Sales per rupee of plant–6.288.32
Capital spending to depreciation–0.810.39
Plant being built, % of plant in use–0.0%0.0%
No balance sheet is on record for the year to Mar 2024, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
3.3%
Cash from operations against operating profit
−42.9%
Measure3 years
Return on equity, average7.6%
Return on capital employed, average9.3%
Operating margin, average7.7%
Net margin, average3.0%
Asset turnover, average1.08
Cash conversion cycle, days, average160
Interest cover, average2.5
Debt to equity, average0.55

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations−7.6
Cash from investing1.6
Cash from financing21.9
Capital spending1.9
Dividends paid0.0
Shares bought back0.0
Shares issued for cash0.0
Borrowings raised2.3
Borrowings repaid30.7

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2024Mar 2025Mar 2026
Altman Z-scorePublished threshold 1.81–2.642.40
Beneish M-scorePublished threshold −1.78––−2.20
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––6.44
Receivables growth less revenue growthOur threshold 0 percentage points––3.70
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––37.47
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––2.66
Effective tax ratePublished threshold 17.16 per cent25.8028.1529.65
Tax charged less tax paid, % of profitOur threshold 10 percentage points–0.320.44
A threshold marked as ours has no published figure; it is the line we read the check against.